Alpha-1,3-glucan graft copolymers

US11098334B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11098334-B2
Application numberUS-201816218518-A
CountryUS
Kind codeB2
Filing dateDec 13, 2018
Priority dateDec 14, 2017
Publication dateAug 24, 2021
Grant dateAug 24, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions are disclosed herein comprising a graft copolymer that comprises: (i) a backbone comprising dextran that has been modified with about 1%-25% alpha-1,2 branches, and (ii) one or more alpha-1,3-glucan side chains comprising at least about 50% alpha-1,3 glycosidic linkages. Further disclosed are reactions for producing such graft copolymers, as well as their use in derivatives, films and various other applications.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition comprising a graft copolymer, or an ether- or ester-derivative thereof, wherein said graft copolymer comprises: (i) a backbone comprising a dextran that has been modified with about 1%-25% alpha-1,2 branches, wherein the weight-average degree of polymerization (DPw) of the backbone is 10 to 500, and (ii) one or more alpha-1,3-glucan side chains comprising at least about 50% alpha-1,3 glycosidic linkages. 2. The composition of claim 1 , wherein said dextran is substantially linear dextran that has been modified with about 1%-25% alpha-1,2 branches. 3. The composition of claim 1 , wherein the dextran has been modified with about 5%-20% alpha-1,2 branches. 4. The composition of claim 1 , wherein the dextran has been modified with 5%-15% alpha-1,2 branches. 5. The composition of claim 1 , wherein the DPw of the backbone is about 10 to 200. 6. The composition of claim 1 , wherein the alpha-1,3-glucan side chains comprise at least about 90% alpha-1,3 glycosidic linkages. 7. The composition of claim 1 , wherein the DP or DPw of said one or more alpha-1,3-glucan side chains is at least about 10. 8. The composition of claim 1 , wherein the composition comprises the graft copolymer. 9. The composition of claim 1 , wherein the composition comprises the ether-derivative of the graft copolymer. 10. The composition of claim 1 , wherein the composition is a household care product, personal care product, industrial product, pharmaceutical product, or food product. 11. The composition of claim 1 , wherein the composition is a film or coating. 12. The composition of claim 1 , wherein said graft copolymer comprises one or two of said alpha-1,3-glucan side chains. 13. The composition of claim 1 , wherein the composition is a detergent composition. 14. A method of producing a graft copolymer, said method comprising: (a) contacting at least (i) water, (ii) sucrose, (iii) dextran that has been modified with about 1%-25% alpha-1,2 branches and having a weight-average degree of polymerization (DPw) of 10 to 500, and (iv) a glucosyltransferase enzyme that synthesizes alpha-1,3-glucan comprising at least about 50% alpha-1,3 glycosidic linkages, whereby a graft copolymer according to the composition of claim 1 is produced; and (b) optionally, isolating the graft copolymer produced in step (a). 15. The method of claim 14 , wherein said dextran is substantially linear dextran that has been modified with about 1%-25% alpha-1,2 branches. 16. The method of claim 14 , wherein the dextran has been modified with about 5%-20% alpha-1,2 branches. 17. The method of claim 14 , wherein the dextran has been modified with 5%-15% alpha-1,2 branches. 18. The method of claim 14 , wherein the dextran has a DPw of 10 to 200. 19. The method of claim 14 , wherein said graft copolymer comprises one or two of said alpha-1,3-glucan side chains. 20. A method for producing a film or coating, said method comprising: (a) dissolving the graft copolymer, or ether- or ester-derivative thereof, of claim 1 in a solvent to provide a solution; (b) contacting the solution with a surface; and (c) removing the solvent to form a film or coating. 21. The method of claim 20 , wherein the solution of (a) comprises less than 15 wt % of the graft copolymer or ether- or ester-derivative thereof. 22. A method of producing alpha-1,3-glucan, said method comprising: (a) contacting at least (i) water, (ii) sucrose, (iii) dextran that has been modified with about 1%-50% alpha-1,2 branches and having a weight-average degree of polymerization (DPw) of 10 to 500, and (iv) a glucosyltransferase enzyme that synthesizes alpha-1,3-glucan comprising at least about 50% alpha-1,3 glycosidic linkages, thereby providing an enzymatic reaction, whereby alpha-1,3-glucan comprising at least about 50% alpha-1,3 glycosidic linkages is produced, and (b) optionally, isolating the alpha-1,3-glucan produced in step (a).

Assignees

Inventors

Classifications

  • C08L5/02Primary

    Dextran; Derivatives thereof · CPC title

  • produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins · CPC title

  • Dextran; Derivatives thereof · CPC title

  • Polyethers, e.g. polyalkyleneoxides · CPC title

  • Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11098334B2 cover?
Compositions are disclosed herein comprising a graft copolymer that comprises: (i) a backbone comprising dextran that has been modified with about 1%-25% alpha-1,2 branches, and (ii) one or more alpha-1,3-glucan side chains comprising at least about 50% alpha-1,3 glycosidic linkages. Further disclosed are reactions for producing such graft copolymers, as well as their use in derivatives, films …
Who is the assignee on this patent?
Nutrition & Biosciences Usa 4 Inc
What technology area does this patent fall under?
Primary CPC classification C08L5/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).